category,datetime,headline,id,image,related,source,summary,url
company,1768055132,Gilead price target raised to $154 from $144 at BofA,138069117,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,GILD,Yahoo,"BofA raised the firm’s price target on Gilead (GILD) to $154 from $144 and keeps a Buy rating on the shares. The firm, which switched its valuation method, says the company’s “steady” HIV franchise growth remains core to its Buy thesis as it sees upside from recent and upcoming launches.Claim 70% Off TipRanks PremiumUnlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Stay ahead of the market with the latest news and analysis and maximize your portfolio's pote",https://finnhub.io/api/news?id=25f9baeb28c678072e6b8829ac0b67aad7f9214962cb245a9eba2b8b6681f5d2
company,1768039200,AstraZeneca: Oncology Dominance Justifies New All-Time Highs,138056039,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1357662733/image_1357662733.jpg?io=getty-c-w1536,GILD,SeekingAlpha,AstraZeneca hit a 2026 high on strong oncology/cardiovascular sales.,https://finnhub.io/api/news?id=37fedf41221f724240bb6e5a39b561db6df5999f1666745993872e232235f2b3
